PROFESSIONAL EDITION

The largest community of pharma leaders

Biotechnology

      New Strategic Vision for Biotechnology Innovation Organization

      WASHINGTON--(BUSINESS WIRE)--The Biotechnology Innovation Organization (BIO) today announced a new, strategic direction that will help guide it to achieving long-term goals while maintaining responsiveness...

      Goldfinch Bio Presents Clinical Data from Phase 1 Trial Supporting Advancement of GFB-887 as a Precision Medicine for Patients with Kidney Diseases

      CAMBRIDGE, Mass.--(BUSINESS WIRE)--Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced...

      Transgene and BioInvent to Present Data on Oncolytic Virus BT-001 at the SITC 35th Anniversary Annual Meeting

      STRASBOURG, France & LUND, Sweden--(BUSINESS WIRE)--Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of...

      Confo Therapeutics Announces Selection of First Product Candidate and Initiation of Pre-Clinical Development

      GHENT, Belgium--(BUSINESS WIRE)--Confo Therapeutics today announced the selection of its first preclinical drug candidate, CFTX-1554, a compound designed to address peripheral neuropathic pain with...

      BryoLogyx Announces Completion of World’s First GMP Synthesis of Bryostatin-1

      DANVILLE, Calif.--(BUSINESS WIRE)--BryoLogyx, Inc., today announced that it has completed the synthesis of bryostatin-1 molecule, pursuant to FDA’s Good Manufacturing Practice (GMP) regulations. Bryostatin-1...

      Recent Articles

      Post